Skip to main content
SpringerLink
Log in
Book cover

Myasthenia Gravis and Related Disorders pp 227–238Cite as

Acquired Neuromyotonia

  • Chapter
  • First Online:

  • 1767 Accesses

Part of the book series: Current Clinical Neurology ((CCNEU))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

REFERENCES

  1. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 1993;116:453–469.

    Article  PubMed  Google Scholar 

  2. Denny-Brown D, Foley DM. Myokymia and the benign fasciculation of muscular cramps. Trans Assoc Am Physicians 1948;61:88–96.

    Google Scholar 

  3. Gamstorp I, Wohlfart G. A syndrome characterized by myokymia, myotonia, muscular wasting and increased perspiration. Acta Psychiatr Scand 1959; 34:181–194.

    Article  CAS  Google Scholar 

  4. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961;24: 319–325.

    Article  PubMed  CAS  Google Scholar 

  5. Mertens HG, Zschoke S. Neuromyotonie. Klin Wocehenscher 1965;43:917–925.

    Article  CAS  Google Scholar 

  6. Lance JW, Burke D, Pollard J. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann Neurol 1979;5:523–532.

    Article  PubMed  CAS  Google Scholar 

  7. Morvan A, De la chorée fibrillaire. Gaz Hebdon de Med Chirurg 1890;27:173–200.

    Google Scholar 

  8. Serratrice G, Azulay JP. Que reste-t-il de la choreé fibrillaire de Morvan? Rev Neurol 1994;150:257–265.

    PubMed  CAS  Google Scholar 

  9. Halbach M, Homberg V, Freund HJ. Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor–binding antibody. J Neurol (Berlin) 1987;234:433–436.

    CAS  Google Scholar 

  10. Liguori R, Vincent A, Clover L, et al. Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001;124:2417–2426.

    Article  PubMed  CAS  Google Scholar 

  11. Maddison P, Lawn N, Mills KR, Vincent A, Donaghy M. Acquired neuromyotonia in a patient with spinal epidural abscess. Muscle Nerve 1998;21:672–674.

    Article  PubMed  CAS  Google Scholar 

  12. Tahmouch AJ, Alonso RJ, Tahmouch GP, et al. Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 1991;41:1021–1024.

    Google Scholar 

  13. Turner MR, Madkhana A, Ebers GC, Clover L, Vincent A, McGavin G, Sarrigiannis P, Kennett R, Warrell DA. Wasp sting induced autoimmune neuromyotonia J Neurol Neurosurg Psychiatry. 2006;77:704–705.

    CAS  Google Scholar 

  14. Hart IK, Maddison P, Vincent A, Mills K, Newsom-Davis J. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002; 125:1887–1895.

    Google Scholar 

  15. Smith KKE, Claussen GY, Fesenmeier JT, Oh SJ. Myokymia-cramp syndrome: evidence of hyperexcitable peripheral nerve. Muscle Nerve 1994;17:1065–1067.

    Article  PubMed  CAS  Google Scholar 

  16. Wakayama Y, Ohbu S, Machida H. Myasthenia gravis, muscle twitch, hyperhidrosis, and limb pain associated with thymoma: proposal of a possible new myasthenic syndrome. Tohoku J Exp Med 1991;164:285–291.

    Article  PubMed  CAS  Google Scholar 

  17. Ho WKH, Wilson JD. Hypothermia, hyperhidrosis, myokymia and increased urinary excretion of catecholamines associated with a thymoma. Med J Aust 1993;158:787–788.

    PubMed  CAS  Google Scholar 

  18. Gutmann L, Libell D, Gutmann L. When is myokymia neuromyotonia? Muscle Nerve 2001;24:151–153.

    Article  PubMed  CAS  Google Scholar 

  19. Maddison P, Mills KR, Newsom-Davis J. Clinical, electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability. Muscle Nerve 2006;33:801–808.

    Article  PubMed  Google Scholar 

  20. Isaacs H. Continuous muscle fibre activity in an Indian male with additional evidence of terminal motor fibre abnormality. J Neurol Neurosurg Psychiatry 1967;30:126–133.

    Article  PubMed  CAS  Google Scholar 

  21. Arimura K, Arimura Y, Ng A, et al. The origin of spontaneous discharges in acquired neuromyotonia. A macro EMG study. Muscle Nerve 2005;116:1835–1839.

    Google Scholar 

  22. Deymeer F, Oge AE, Serdaroglu P, et al. The use of botulinum toxin in localizing neuromyotonia to the terminal branches of the peripheral nerve. Muscle Nerve 1998;21:643–646.

    Article  PubMed  CAS  Google Scholar 

  23. García-Merino A, Cabella A, Mora JS, Liaño H. Continuous muscle fiber activity, peripheral neuropathy, and thymoma. Ann Neurol 1991;29:215–218.

    Article  PubMed  Google Scholar 

  24. Irani PF, Purohit AV, Wadia HH. The syndrome of continuous muscle fiber activity. Acta Neurol Scand 1977;55:273–288.

    Article  PubMed  CAS  Google Scholar 

  25. Partanen VSJ, Soininen H, Saksa M, Riekkinen P. Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer. Acta Neurol Scand 1980;61:216–226.

    Article  PubMed  CAS  Google Scholar 

  26. Hosokawa S, Shinoda H, Sakai T, Kato M, Kuroiwa Y. Electrophysiological study on limb myokymia in three women. J Neurol Neurosurg Psychiatry 1987;50:877–881.

    Article  PubMed  CAS  Google Scholar 

  27. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998;21:137–158.

    Article  PubMed  CAS  Google Scholar 

  28. Burke D. Excitability of motor axons in neuromyotonia. Muscle Nerve 1999;22:797–799.

    Article  PubMed  CAS  Google Scholar 

  29. Maddison P, Newsom-Davis J, Mills KR. Strength-duration properties of peripheral nerve in acquired neuromyotonia. Muscle Nerve 1999;22: 823–830.

    Article  PubMed  CAS  Google Scholar 

  30. Kiernan MC, Hart IK, Bostock H. Excitability of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry 2001;70:56–64.

    Article  PubMed  CAS  Google Scholar 

  31. Harman JB, Richardson AT. Generalized myokymia in thyrotoxicosis: report of a case. Lancet 1954;2:473–474.

    Article  Google Scholar 

  32. Reeback J, Benton S, Swash M, Schwartz MS. Penicillamine-induced neuromyotonia. Brit Med J 1979;279:1464–1465.

    Article  Google Scholar 

  33. Vilchez JJ, Cabello A, Benedito J, Villarroya T. Hyperkalaemic paralysis, neuropathy and persistent motor unit discharges at rest in Addison's disease. J Neurol Neurosurg Psychiatry 1980;43:818–822.

    Article  PubMed  CAS  Google Scholar 

  34. Benito-Leon J, Martin E, Vincent A, Fernandez-Lorente J, de Blas G. Neuromyotonia in association with essential thrombocythemia. J Neurol Sci 2000:173:78–79.

    Article  PubMed  CAS  Google Scholar 

  35. Gutmann L, Gutmann L, Schochet SS. Neuromyotonia and type 1 myofiber predominance in amyloidosis. Muscle Nerve 1996;19:1338–1341.

    Article  PubMed  CAS  Google Scholar 

  36. Hadjivassiliou M, Chattopadhyay AK, Davies-Jones GA, et al. Neuromuscular disorder as a presenting feature of coeliac disease. J Neurol Neurosurg Psychiatry 1997;63:770–775.

    Article  PubMed  CAS  Google Scholar 

  37. Le Gars L, Clerc D, Cariou D, et al. Systemic juvenile rheumatoid arthritis and associated Isaacs' syndrome. J Rheumatol 1997;24:178–180.

    PubMed  Google Scholar 

  38. Benito-Leon J, Miguelez R, Vincent A, et al. Neuromyotonia in association with systemic sclerosis. J Neurol 1999;246:976–977.

    Article  PubMed  CAS  Google Scholar 

  39. Liguori R, Vincent A, Avoni P, et al. Acquired neuromyotonia after bone marrow transplantation. Neurology 2000;54:1390–1931

    PubMed  CAS  Google Scholar 

  40. Vasilescu C, Alexianu M, Dan A. Muscle hypertrophy and a syndrome of continuous motor unit activity in prednisone-responsive Guillain–Barré polyneuropathy. J Neurol (Berlin) 1984;231:276–279.

    CAS  Google Scholar 

  41. Caress JB, Abend WK, Preston DC, Logigian EL. A case of Hodgkin's lymphoma producing neuromyotonia. Neurology, 1997;49:258–259.

    PubMed  CAS  Google Scholar 

  42. Zifko U, Drlicek M, Machacek E, et al. Syndrome of continuous muscle fiber activity and plasmacytoma with IgM paraproteinemia. Neurology 1994;44:560–561.

    PubMed  CAS  Google Scholar 

  43. Sinha S, Newsom-Davis J, Mills K, et al. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 1991;338: 75–77.

    Article  PubMed  CAS  Google Scholar 

  44. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 1995;38:714–722.

    Article  PubMed  CAS  Google Scholar 

  45. Harvey AL, Rowan EG, Vatanpour H, Fatehi M, Castaneda O, Karlsson E. Potassium channel toxins and transmitter release. Ann NY Acad Sci 1994;710:1–10.

    Article  PubMed  CAS  Google Scholar 

  46. Ramaswami R, Gautam, M, Kamb A, et al. Human potassium channel genes: molecular cloning and functional expression. Mol Cell Neurosci 1990;1:214–223.

    Article  PubMed  CAS  Google Scholar 

  47. Kleopa KA, Elman LB, Lang B, Vincent A, Scherer SS. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain. 2006 Jun;129 (Part 6):1570–1584. Epub 2006 Apr 13.

    Article  PubMed  Google Scholar 

  48. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238–46

    Article  PubMed  CAS  Google Scholar 

  49. Rettig J, Heinemann SH, Wunder F, et al. Inactivation properties of voltage-gated potassium channels altered by presence of β-subunit. Nature 1994;369:289–294.

    Article  PubMed  CAS  Google Scholar 

  50. Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A. IgG1 antibodies to acetylcholine receptors in “seronegative” MG. Brain 2008;131:1940–1952.

    Google Scholar 

  51. Arimura K, Watanabe O, Kitajima I, et al. Antibodies to potassium channels of PC12 in serum of Isaacs' syndrome: western blot and immunohistochemical studies. Muscle Nerve 1997;20:299–305

    Article  PubMed  CAS  Google Scholar 

  52. Sonoda Y, Arimura K, Kurono A, et al. Serum of Isaacs' syndrome suppresses potassium channels in PC-12 cell lines. Muscle Nerve 1996;19:1439–1446.

    Article  PubMed  CAS  Google Scholar 

  53. Nagado T, Arimura K, Sonoda Y, et al. Potassium current suppression in patients with peripheral nerve hyperexcitability. Brain 1999;122:2057–2066.

    Article  PubMed  Google Scholar 

  54. Tomimitsu H, Arimura K, Nagado T, et al. Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia. Annals Neurol 2004;56:440–444.

    Article  CAS  Google Scholar 

  55. O'Hanlon GM, Plomp JJ, Chakrabarti M, et al. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 2001;124:893–906

    Article  PubMed  Google Scholar 

  56. Verino S, Adamski J, Kryzer TJ, et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998;50:1806–1813.

    Google Scholar 

  57. Toyka KV, Zielasek J, Ricker K, et al. Hereditary neuromyotonia: a mouse model associated with deficiency or increased gene dosage of the PMP22 gene. J Neurol Neurosurg Psychiatry 1997;63:812–813.

    Article  PubMed  CAS  Google Scholar 

  58. Zielasek J, Martini R, Suter U, Toyka KV. Neuromyotonia in mice with hereditary myelinopathies. Muscle Nerve 2000;23:696–701.

    Article  PubMed  CAS  Google Scholar 

  59. Vincent A. Understanding neuromyotonia. Muscle Nerve 2000;23:655–657.

    Article  PubMed  CAS  Google Scholar 

  60. Verino S, Auger RG, Emslie-Smith AM, et al. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 1999;53:1233–1239.

    Google Scholar 

  61. Hart IK, Leys K, Vincent A, et al. Autoantibodies to voltage-gated potassium channels in acquired neuromyotonia. Neuromusc Disord 1994;4:535(Abstr.).

    Article  Google Scholar 

  62. Hart IK, Waters C, Newsom-Davis J. Cerebrospinal fluid and serum from acquired neuromyotonia patients seropositive for anti-potassium channel antibodies label dentate nucleus neurones. Ann Neurol 1996;40:554–555.

    Google Scholar 

  63. Josephs KA, Silber MH, Fealey RD, et al. Neurophysiologic studies in Morvan 2004;21:440–445.

    Google Scholar 

  64. Batocchi AP, Marca GD, Mirabella, M, et al. Relapsing-remitting autoimmune agrypnia. Ann Neurol 2001;50:668–671.

    Article  PubMed  CAS  Google Scholar 

  65. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:74–79

    Google Scholar 

  66. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy- responsive form of limbic encephalitis. Brain. 2004 Mar;127(Part 3):701–12. Epub 2004 Feb 11.

    PubMed  Google Scholar 

  67. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004 Apr 13;62(7):1177–1182.

    PubMed  CAS  Google Scholar 

  68. Vincent A, Lang B, Kleopa KA.Autoimmune channelopathies and related neurological disorders. Neuron 2006 Oct 5;52(1):123–138.

    Article  PubMed  CAS  Google Scholar 

  69. Ishii A, Hayashi A, Ohkoshi N, et al. Clinical evaluation of plasma exchange and high dose intravenous immunoglobulin in a patient with Isaacs' syndrome. J Neurol Neurosurg Psychiatry 1994;57:840–842.

    Article  PubMed  CAS  Google Scholar 

  70. Van den Berg JS, van Engelen BG, Boerman RH, de Baets MH. Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin. J Neurol 1999;246:623–625.

    Article  PubMed  Google Scholar 

  71. Skeie GO, Apostolski S, Evoli A, Gilhus NE, Hart IK, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2006 Jul;13(7):691–699.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Molecular Medicine, John Radcliffe Hospital and Oxford University, Oxford, UK

    Angela Vincent

  2. Department of Neurological Science, Walton Centre for Neurology and Neurosurgery, Liverpool, UK

    Ian Hart

Authors
  1. Angela Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ian Hart
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Vincent, A., Hart, I. (2009). Acquired Neuromyotonia. In: Myasthenia Gravis and Related Disorders. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-156-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-156-7_14

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-852-2

  • Online ISBN: 978-1-59745-156-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation